Stem cell reviews and reports2024; doi: 10.1007/s12015-024-10693-8

Equine Embryonic Stem Cell-Derived Tenocytes are Insensitive to a Combination of Inflammatory Cytokines and Have Distinct Molecular Responses Compared to Primary Tenocytes.

Abstract: Tissue fibrosis following tendon injury is a major clinical problem due to the increased risk of re-injury and limited treatment options; however, its mechanism remains unclear. Evidence suggests that insufficient resolution of inflammation contributes to fibrotic healing by disrupting tenocyte activity, with the NF-κB pathway being identified as a potential mediator. Equine embryonic stem cell (ESC) derived tenocytes may offer a potential cell-based therapy to improve tendon regeneration, but how they respond to an inflammatory environment is largely unknown. Our findings reveal for the first time that, unlike adult tenocytes, ESC-tenocytes are unaffected by IFN-γ, TNFα, and IL-1β stimulation; producing minimal changes to tendon-associated gene expression and generating 3-D collagen gel constructs indistinguishable from unstimulated controls. Inflammatory pathway analysis found these inflammatory cytokines failed to activate NF-κB in the ESC-tenocytes. However, NF-κB could be activated to induce changes in gene expression following stimulation with NF-κB pharmaceutical activators. Transcriptomic analysis revealed differences between cytokine and NF-κB signalling components between adult and ESC-tenocytes, which may contribute to the mechanism by which ESC-tenocytes escape inflammatory stimuli. Further investigation of these molecular mechanisms will help guide novel therapies to reduce fibrosis and encourage superior tendon healing.
Publication Date: 2024-02-24 PubMed ID: 38396222PubMed Central: 4195467DOI: 10.1007/s12015-024-10693-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores how tenocytes, a type of cell found in tendons, derived from equine or horse embryonic stem cells behave in inflammatory conditions. It was found that these stem cell-derived tenocytes, unlike adult tenocytes, do not respond to inflammation due to certain genes and produce minimal changes.

Background

  • This research targets the challenge of tissue fibrosis after a tendon injury, which poses a risk as it leads to re-injury and there are limited treatment options available. The mechanisms of fibrosis aren’t well understood.
  • This study works on the hypothesis that insufficient resolution of inflammation contributes to fibrotic healing and disturbs tenocyte activity.
  • It recognizes the NF-κB pathway as a potential mediator in the process.

Research Aim

  • The research was designed to explore equine embryonic stem cell (ESC) derived tenocytes’ response to inflammation, as these can potentially be used to improve tendon regeneration.

Research Findings

  • The research found that ESC-derived tenocytes, unlike adult tenocytes, are not affected by inflammatory cytokines IFN-γ, TNFα, and IL-1β.
  • They produced minimal changes in tendon-associated gene expression after stimulation with these cytokines.
  • They also produced 3-D collagen gel constructs equivalent to unstimulated controls.
  • The pathway analysis revealed that these inflammatory cytokines did not activate the NF-κB pathway in ESC-tenocytes, which is a new finding in this field.
  • However, it was found that this pathway could be activated using pharmaceutical activators.

Transcriptomic Analysis

  • A deeper analysis of genes showed differences between adult tenocytes and ESC-derived tenocytes with respect to cytokine and NF-κB signalling components.
  • These differences may explain why ESC-derived tenocytes are unaffected by inflammatory stimuli.

Summary

  • This research adds to our understanding of how tenocytes respond to inflammation and further exploration of these mechanisms can lead to novel therapies aimed to decrease fibrosis and improve tendon healing.

Cite This Article

APA
Smith EJ, Beaumont RE, Dudhia J, Guest DJ. (2024). Equine Embryonic Stem Cell-Derived Tenocytes are Insensitive to a Combination of Inflammatory Cytokines and Have Distinct Molecular Responses Compared to Primary Tenocytes. Stem Cell Rev Rep. https://doi.org/10.1007/s12015-024-10693-8

Publication

ISSN: 2629-3277
NlmUniqueID: 101752767
Country: United States
Language: English

Researcher Affiliations

Smith, Emily J
  • Department of Clinical Sciences and Services, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts, AL9 7TA, UK. ejsmith@rvc.ac.uk.
Beaumont, Ross E
  • Department of Clinical Sciences and Services, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts, AL9 7TA, UK.
Dudhia, Jayesh
  • Department of Clinical Sciences and Services, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts, AL9 7TA, UK.
Guest, Deborah J
  • Department of Clinical Sciences and Services, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Herts, AL9 7TA, UK. djguest@rvc.ac.uk.

Grant Funding

  • VET/RS/257 / Horserace Betting Levy Board
  • S19-747- 786 / Petplan Charitable Trust

References

This article includes 69 references
  1. Lichtwark, G. A., & Wilson, A. M. (2005). In vivo mechanical properties of the human Achilles tendon during one-legged hopping. Journal of Experimental Biology, 208, 4715u20134725. https://doi.org/10.1242/jeb.01950
    doi: 10.1242/jeb.01950pubmed: 16326953google scholar: lookup
  2. Biewener, A. A. (1998). Muscle-tendon stresses and elastic energy storage during locomotion in the horse. Comparative Biochemistry and Physiology. B, 120, 73u201387.
  3. James, R., Kesturu, G., Balian, G., & Chhabra, B. A. (2008). Tendon: Biology, biomechanics, repair, growth factors, and evolving treatment options. The Journal of Hand Surgery, 33A(February), 102u2013122. https://doi.org/10.1016/j.jhsa.2007.09.007
  4. Nourissat, G., Berenbaum, F., & Duprez, D. (2015). Tendon injury: From biology to tendon repair. Nature Reviews Rheumatology, 11(4), 223u2013233. https://doi.org/10.1038/nrrheum.2015.26
    doi: 10.1038/nrrheum.2015.26pubmed: 25734975google scholar: lookup
  5. Williams, R. B., Harkins, L. S., Hammond, C. J., & Wood, J. L. N. (2001). Racehorse injuries, clinical problems and fatalities recorded on British racecourses from flat racing and National Hunt racing during 1996, 1997 and 1998. Equine Veterinary Journal, 33(5), 478u2013486. https://doi.org/10.2746/042516401776254808
    doi: 10.2746/042516401776254808pubmed: 11558743google scholar: lookup
  6. Yang, G., Rothrauff B. B., Tuan, R. S. (2013). Tendon and ligament regeneration and repair: Clinical relevance and developmental paradigm. Birth Defects Research, Part C: Embryo Todayu2014Reviews. 99(Part C), 203u2013222. https://doi.org/10.1002/bdrc.21041
  7. Dyson, S. J. (2004). Medical management of superficial digital flexor tendonitis: A comparative study in 219 horses (1992u20132000). Equine Veterinary Journal, 36(5), 415u2013419. https://doi.org/10.2746/0425164044868422
    doi: 10.2746/0425164044868422pubmed: 15253082google scholar: lookup
  8. Dudhia, J., Scott, C. M., Draper, E. R. C., Heinegu00e5rd, D., Pitsillides, A. A., & Smith, R. K. (2007). Aging enhances a mechanically-induced reduction in tendon strength by an active process involving matrix metalloproteinase activity. Aging Cell, 6(4), 547u2013556. https://doi.org/10.1111/j.1474-9726.2007.00307.x
  9. Cassel, M., Baur, H., Hirschmu00fcller, A., Carlsohn, A., Fru00f6hlich, K., & Mayer, F. (2015). Prevalence of Achilles and patellar tendinopathy and their association to intratendinous changes in adolescent athletes. Scandinavian Journal of Medicine & Science in Sports, 25(3), e310u2013e318. https://doi.org/10.1111/sms.12318
    doi: 10.1111/sms.12318google scholar: lookup
  10. Patterson-Kane, J. C., & Rich, T. (2014). Achilles tendon injuries in elite athletes: Lessons in pathophysiology from their equine counterparts. ILAR Journal, 55(1), 86u201399. https://doi.org/10.1093/ilar/ilu004
    doi: 10.1093/ilar/ilu004pubmed: 24936032google scholar: lookup
  11. Dakin, S. G., et al. (2015). Inflammation activation and resolution in human tendon disease. Science Translational Medicine, 7(311), 1u201331. https://doi.org/10.1126/scitranslmed.aac4269
  12. Goodier, H. C. J., et al. (2016). Comparison of transforming growth factor beta expression in healthy and diseased human tendon. Arthritis Research & Therapy, 19(48), 1u201310. https://doi.org/10.1186/s13075-016-0947-8
    doi: 10.1186/s13075-016-0947-8google scholar: lookup
  13. Smith, E. J., et al. (2023). Tumour necrosis factor alpha, interleukin 1 beta and interferon gamma have detrimental effects on equine tenocytes that cannot be rescued by IL-1RA or mesenchymal stromal cellu2013derived factors. Cell and Tissue Research, 391(3), 523u2013544. https://doi.org/10.1007/s00441-022-03726-6
    doi: 10.1007/s00441-022-03726-6pubmed: 36543895google scholar: lookup
  14. Tsai, C. L., Chen, W. C., Hsieh, H. L., Chi, P. L., Der Hsiao, L., & Yang, C. M. (2014). TNF-u03b1 induces matrix metalloproteinase-9-dependent soluble intercellular adhesion molecule-1 release via TRAF2-mediated MAPKs and NF-u03baB activation in osteoblast-like MC3T3-E1 cells. Journal of Biomedical Science, 21(12), 1u201319. https://doi.org/10.1186/1423-0127-21-12
    doi: 10.1186/1423-0127-21-12google scholar: lookup
  15. Wang, Y., et al. (2019). Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway. Cell Proliferation, 52(4), 1u201312. https://doi.org/10.1111/cpr.12650
    doi: 10.1111/cpr.12650google scholar: lookup
  16. Freedman, B. R., et al. (2022). Nonsurgical treatment reduces tendon inflammation and elevates tendon markers in early healing. Journal of Orthopaedic Research. 1u201312. https://doi.org/10.1002/jor.25251
  17. Beaumont, R. E., Smith, E. J., Zhou, L., Marr, N., Thorpe, C. T., Guest, D. J. (2023). Exogenous interleukinu20111 beta stimulation regulates equine tenocyte function and gene expression in threeu2011dimensional culture which can be rescued by pharmacological inhibition of interleukin 1 receptor, but not nuclear factor kappa B, signalling. Molecular and Cellular Biochemistry, (0123456789). https://doi.org/10.1007/s11010-023-04779-z
  18. Sun, J., & Nan, G. (2016). The Mitogen-Activated Protein Kinase (MAPK) signaling pathway as a discovery target in stroke. Journal of Molecular Neuroscience, 59(1), 90u201398. https://doi.org/10.1007/s12031-016-0717-8
    doi: 10.1007/s12031-016-0717-8pubmed: 26842916google scholar: lookup
  19. Millar, N. L., Murrell, G. A. C., & McInnes, I. B. (2017). Inflammatory mechanisms in tendinopathy - towards translation. Nature Reviews Rheumatology, 13(2), 110u2013122. https://doi.org/10.1038/nrrheum.2016.213
    doi: 10.1038/nrrheum.2016.213pubmed: 28119539google scholar: lookup
  20. Abraham, A. C., Shah, S. A., & Thomopoulos, S. (2017). Targeting inflammation in rotator cuff tendon degeneration and repair. Techniques in Shoulder & Elbow Surgery, 18(3), 84u201390. https://doi.org/10.1097/BTE.0000000000000124
  21. Spaas, J. H., Guest, D. J., & Van De Walle, G. R. (2012). Tendon regeneration in human and equine athletes. Sports Medicine, 42(10), 871u2013890.
    doi: 10.1007/BF03262300pubmed: 22963225google scholar: lookup
  22. Smith, R. K. W., Werling, N. J., Dakin, S. G., Alam, R., Goodship, A. E., & Dudhia, J. (2013). Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy. PLoS ONE, 8(9), 1u201314. https://doi.org/10.1371/journal.pone.0075697
  23. Guest, D., Ousey, J. C., & Smith, M. R. (2008). Defining the expression of marker genes in equine mesenchymal stromal cells. Stem Cells and Cloning: Advances and Applications, 1, 1u20139. https://doi.org/10.2147/sccaa.s3824
    doi: 10.2147/sccaa.s3824pubmed: 24198500google scholar: lookup
  24. Godwin, E. E., Young, N. J., Dudhia, J., Beamish, I. C., & Smith, R. K. W. (2012). Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Veterinary Journal, 44(1), 25u201332. https://doi.org/10.1111/j.2042-3306.2011.00363.x
  25. Wagner, W., et al. (2009). Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS ONE, 4(6). https://doi.org/10.1371/journal.pone.0005846
  26. Mitalipova, M. M., et al. (2005). Preserving the genetic integrity of human embryonic stem cells. Nature Biotechnology, 23(1), 19u201320. https://doi.org/10.1038/nbt0105-19
    doi: 10.1038/nbt0105-19pubmed: 15637610google scholar: lookup
  27. Hentze, H., Soong, P. L., Wang, S. T., Phillips, B. W., Putti, T. C., & Dunn, N. R. (2009). Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res., 2(3), 198u2013210. https://doi.org/10.1016/j.scr.2009.02.002
    doi: 10.1016/j.scr.2009.02.002pubmed: 19393593google scholar: lookup
  28. Guest, D. J., & Allen, W. R. (2007). Expression of cell-surface antigens and embryonic stem cell pluripotency genes in equine blastocysts. Stem Cells Dev., 16(5), 789u2013795. https://doi.org/10.1089/scd.2007.0032
    doi: 10.1089/scd.2007.0032pubmed: 17999600google scholar: lookup
  29. Guest, D. J., Smith, M. R. W., & Allen, W. R. (2010). Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Veterinary Journal, 42(7), 636u2013642. https://doi.org/10.1111/j.2042-3306.2010.00112.x
  30. Li, X., Zhou, S. G., Imreh, M. P., u00c4hrlund-Richter, L., & Allen, W. R. (2006). Horse embryonic stem cell lines from the proliferation of inner cell mass cells. Stem Cells and Development, 15(4), 523u2013531. https://doi.org/10.1089/scd.2006.15.523
    doi: 10.1089/scd.2006.15.523pubmed: 16978056google scholar: lookup
  31. Barsby, T., Bavin, E. P., & Guest, D. J. (2014). Three-dimensional culture and transforming growth factor beta3 synergistically promote tenogenic differentiation of equine embryo-derived stem cells. Tissue Engineering Part A, 20(19u201320), 2604u20132613. https://doi.org/10.1089/ten.tea.2013.0457
    doi: 10.1089/ten.tea.2013.0457pubmed: 24628376pmc: 4195467google scholar: lookup
  32. Barsby, T., & Guest, D. (2013). Transforming growth factor beta3 promotes tendon differentiation of equine embryo-derived stem cells. Tissue Engineering Part A, 19(19u201320), 2156u20132165. https://doi.org/10.1089/ten.tea.2012.0372
    doi: 10.1089/ten.tea.2012.0372pubmed: 23611525google scholar: lookup
  33. Paterson, Y. Z., Cribbs, A., Espenel, M., Smith, E. J., Henson, F. M. D., & Guest, D. J. (2020) Genome-wide transcriptome analysis reveals equine embryonic stem cell-derived tenocytes resemble fetal, not adult tenocytes. Stem cell research & therapy, 11(184), 1u201314. https://doi.org/10.1186/s13287-020-01692-w
  34. McClellan, A., Evans, R., Sze, C., Kan, S., Paterson, Y., & Guest, D. (2019). A novel mechanism for the protection of embryonic stem cell derived tenocytes from inflammatory cytokine interleukin 1 beta. Science and Reports, 9(1), 1u201312. https://doi.org/10.1038/s41598-019-39370-4
  35. John, T., et al. (2010). Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes. Journal of Orthopaedic Research, 28(8), 1071u20131077. https://doi.org/10.1002/jor.21079
    doi: 10.1002/jor.21079pubmed: 20127972google scholar: lookup
  36. McClellan, A., Paterson, Y. Z., Paillot, R., & Guest, D. J. (2019). Equine fetal, adult, and embryonic stem cell-derived tenocytes are all immune privileged but exhibit different immune suppressive properties in vitro. Stem Cells and Development, 28(21), 1413u20131423. https://doi.org/10.1089/scd.2019.0120
    doi: 10.1089/scd.2019.0120pubmed: 31507234google scholar: lookup
  37. Bavin, E. P., Atkinson, F., Barsby, T., & Guest, D. J. (2017). Scleraxis is essential for tendon differentiation by equine embryonic stem cells and in equine fetal tenocytes. Stem Cells and Development, 26(6), 441u2013450. https://doi.org/10.1089/scd.2016.0279
    doi: 10.1089/scd.2016.0279pubmed: 27899062google scholar: lookup
  38. Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017). Salmon: Fast and bias-aware quantification of transcript expression using dual-phase inference. Nature Methods, 14(4), 417u2013419. https://doi.org/10.1038/nmeth.4197.Salmon
    doi: 10.1038/nmeth.4197.Salmonpubmed: 28263959pmc: 5600148google scholar: lookup
  39. Soneson, C., Love, M. I., Robinson, M. D. (2016). Differential analyses for RNA-seq: Transcript-level estimates improve gene-level inferences. F1000Research, 4 (1521), 1u201323. https://doi.org/10.12688/F1000RESEARCH.7563.2
  40. Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-u0394u0394CT method. Methods, 25(4), 402u2013408. https://doi.org/10.1006/meth.2001.1262
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  41. Sander, H., Wallace, S., Plouse, R., Tiwari, S., Aldrin, V. Gomes. (2019). Ponceau S Waste: Ponceau S Staining for Total Protein Normalization. Analytical Biochemistry, 15(575), 44u201353. https://doi.org/10.1016/j.ab.2019.03.010.Ponceau
  42. Bell, E., Ivarsson, B., & Merrill, C. (1979). Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proceedings of the National Academy of Sciences of the United States of America, 76(3), 1274u20131278. https://doi.org/10.1073/pnas.76.3.1274
    doi: 10.1073/pnas.76.3.1274pubmed: 286310pmc: 383233google scholar: lookup
  43. Yang, T. H., et al. (2015). Collagen gel contraction as a measure of fibroblast function in an animal model of subsynovial connective tissue fibrosis. Journal of Orthopaedic Research, 33(5), 668u2013674. https://doi.org/10.1002/jor.22835
    doi: 10.1002/jor.22835pubmed: 25626430pmc: 4415498google scholar: lookup
  44. Zampetaki, A., Zeng, L., Xiao, Q., Margariti, A., Hu, Y., & Xu, Q. (2007). Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-u03b1 is rescued by HDAC inhibitor trichostatin A. American Journal of Physiology. Cell Physiology, 293(4), 1226u20131238. https://doi.org/10.1152/ajpcell.00152.2007
  45. Du2019Angelo, W., et al. (2017). The molecular basis for the lack of inflammatory responses in mouse embryonic stem cells and their differentiated cells. The Journal of Immunology, 198(5), 2147u20132155. https://doi.org/10.4049/jimmunol.1601068
    doi: 10.4049/jimmunol.1601068pubmed: 28130495google scholar: lookup
  46. Sidney, L. E., Kirkham, G. R., & Buttery, L. D. (2014). Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1u03b2, TNF-u03b1, and IFN-u03b3. Stem Cells and Development, 23(6), 605u2013617. https://doi.org/10.1089/scd.2013.0336
    doi: 10.1089/scd.2013.0336pubmed: 24192281google scholar: lookup
  47. Fu00f6ldes, G., et al., (2010). Innate immunity in human embryonic stem cells: Comparison with adult human endothelial cells. PLoS ONE, 5(5). https://doi.org/10.1371/journal.pone.0010501
  48. Kang, H. B., Kim, Y. E., Kwon, H. J., Sok, D. E., & Lee, Y. (2007). Enhancement of NF-u03baB expression and activity upon differentiation of human embryonic stem cell line SNUhES3. Stem Cells and Development, 16(4), 615u2013623. https://doi.org/10.1089/scd.2007.0014
    doi: 10.1089/scd.2007.0014pubmed: 17784835google scholar: lookup
  49. Liu, T., Zhang, L., Joo, D., & Sun, S. C. (2017). NF-u03baB signaling in inflammation. Signal Transduction and Targeted Therapy, 2(e17023), 1u20138. https://doi.org/10.1038/sigtrans.2017.23
    doi: 10.1038/sigtrans.2017.23google scholar: lookup
  50. Best, K. T., Lee, F. K., Knapp, E., Awad, H. A., & Loiselle, A. E. (2019). Deletion of NFKB1 enhances canonical NF-u03baB signaling and increases macrophage and myofibroblast content during tendon healing. Science and Reports, 9(1), 1u201311. https://doi.org/10.1038/s41598-019-47461-5
  51. Abraham, A. C., et al. (2019). Targeting the NF-kB signaling pathway in chronic tendon disease. Science Translational Medicine, 11(eaav4319). https://doi.org/10.1126/scitranslmed.aav4319
  52. Novotny, N. M., Markel, T. A., Crisostomo, P. R., & Meldrum, D. R. (2008). Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: Role of NFkB. Cytokine, 43(2), 215u2013219. https://doi.org/10.1016/j.cyto.2008.05.015
    doi: 10.1016/j.cyto.2008.05.015pubmed: 18621544google scholar: lookup
  53. Millar, N. L., et al. (2016). IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy. Science and Reports, 6(May), 1u201311. https://doi.org/10.1038/srep27149
    doi: 10.1038/srep27149google scholar: lookup
  54. Du2019Angelo, W., et al. (2016). Development of antiviral innate immunity during in vitro differentiation of mouse embryonic stem cells. Stem Cells and Development, 25(8), 648u2013659. https://doi.org/10.1089/scd.2015.0377
    doi: 10.1089/scd.2015.0377pubmed: 26906411pmc: 4834518google scholar: lookup
  55. Guo, W., et al. (2018). NF-KappaB pathway is involved in bone marrow stromal cell-produced pain relief. Frontiers in Integrative Neuroscience, 12(October), 1u201310. https://doi.org/10.3389/fnint.2018.00049
    doi: 10.3389/fnint.2018.00049google scholar: lookup
  56. Gaeta, M. Lou, Johnson, D. R., Kluger, M. S., Pober, J. S. (2000). The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for golgi retention of the receptor and mediates receptor desensitization. Laboratory Investigation, 80(8), 1185u20131184. https://doi.org/10.1203/00006450-199904020-00238
  57. Bradley, J. R., Thiru, S., & Pober, J. S. (1995). Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. American Journal of Pathology, 146(1), 27u201332.
    pubmed: 7856733pmc: 1870772
  58. Kaltschmidt, C., Greiner, J. F. W., & Kaltschmidt, B. (2021). The transcription factor NF-kB in stem cells and development. Cells, 10(2042), 1u201317. https://doi.org/10.3390/cells10082042
    doi: 10.3390/cells10082042google scholar: lookup
  59. Guo, Y. L., Kang, B., Yang, L. J., & Williamson, J. R. (1999). Tumor necrosis factor-u03b1 and ceramide induce cell death through different mechanisms in rat mesangial cells. American Journal of Physiology. Renal Physiology, 276(45), F390u2013F397. https://doi.org/10.1152/ajprenal.1999.276.3.f390
  60. Nowak, D. E., Tian, B., & Brasier, A. R. (2005). Two-step cross-linking method for identification of NF-u03baB gene network by chromatin immunoprecipitation. BioTechniques, 39(5), 715u2013724. https://doi.org/10.2144/000112014
    doi: 10.2144/000112014pubmed: 16315372google scholar: lookup
  61. Lallena, M.-J., Diaz-Meco, M. T., Bren, G., Payu00e1, C. V., & Moscat, J. (1999). Activation of Iu03baB kinase u03b2 by protein kinase C isoforms. Molecular and Cellular Biology, 19(3), 2180u20132188. https://doi.org/10.1128/mcb.19.3.2180
    doi: 10.1128/mcb.19.3.2180pubmed: 10022904pmc: 84010google scholar: lookup
  62. Busuttil, V., et al. (2002). Blocking NF-u03baB activation in Jurkat leukemic T cells converts the survival agent and tumor promoter PMA into an apoptotic effector. Oncogene, 21(20), 3213u20133224. https://doi.org/10.1038/sj.onc.1205433
    doi: 10.1038/sj.onc.1205433pubmed: 12082637google scholar: lookup
  63. Daneshmandi, L., et al. (2020). Emergence of the stem cell secretome in regenerative engineering. Trends in Biotechnology, 38(12), 1373u20131384. https://doi.org/10.1016/j.tibtech.2020.04.013
    doi: 10.1016/j.tibtech.2020.04.013pubmed: 32622558pmc: 7666064google scholar: lookup
  64. Gaida, J. E., Alfredson, H., Forsgren, S., & Cook, J. L. (2016). A pilot study on biomarkers for tendinopathy: Lower levels of serum TNF-u03b1 and other cytokines in females but not males with Achilles tendinopathy. BMC Sports Science, Medicine and Rehabilitation, 8(1), 1u201310. https://doi.org/10.1186/s13102-016-0026-0
    doi: 10.1186/s13102-016-0026-0google scholar: lookup
  65. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992). Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Journal of Experimental Medicine, 175(2), 323u2013329. https://doi.org/10.1084/jem.175.2.323
    doi: 10.1084/jem.175.2.323pubmed: 1310100google scholar: lookup
  66. Wajant, H., & Siegmund, D. (2019). TNFR1 and TNFR2 in the control of the life and death balance of macrophages. Frontiers in Cell and Development Biology, 7(May), 1u201314. https://doi.org/10.3389/fcell.2019.00091
    doi: 10.3389/fcell.2019.00091google scholar: lookup
  67. Chen, B., Gurung, C., Guo, J., Kwon, C., & Guo, Y.-L. (2020). Pluripotent stem cells are insensitive to the cytotoxicity of TNFu03b1 and IFNu03b3. Reproduction, 160(4), 547u2013560. https://doi.org/10.1530/REP-20-0215
    doi: 10.1530/REP-20-0215pubmed: 32698161pmc: 8048085google scholar: lookup
  68. Robertson, S. A., Chin, P. Y., Femia, J. G., Brown, H. M. (2018). Embryotoxic cytokinesu2014Potential roles in embryo loss and fetal programming. American Journal of Reproductive Immunology, 125(December 2017), pp. 80u201388. https://doi.org/10.1016/j.jri.2017.12.003
  69. Guo, Y. L., et al. (2015). Attenuated innate immunity in embryonic stem cells and its implications in developmental biology and regenerative medicine. Stem Cells, 33(11), 3165u20133173. https://doi.org/10.1002/stem.2079
    doi: 10.1002/stem.2079pubmed: 26086534google scholar: lookup

Citations

This article has been cited 0 times.